pharmaceutical investing DelMar Pharmaceuticals Announces First Quarter Fiscal Year 2018 Financial Results
pharmaceutical investing DelMar Pharmaceuticals Announces Closing Of $10 Million Registered Direct Offering Priced At-The-Market
pharmaceutical investing DelMar Pharmaceuticals to Present at the 19th Annual Rodman & Renshaw Global Investment Conference on September 10-12, 2017
DelMar Pharmaceuticals, Inc. – "Optimism and Opportunity as we Initiate Clinical Trials for MGMT-unmethylated GBM Patients at MD Anderson"
DelMar Pharmaceuticals and Accurexa to Collaborate in the Development of a Novel Combination Chemotherapy
Metalsource Mining Strengthens Strategic Communications and Market Awareness as Exploration Advances at America's First Silver Mine
Sun Summit Commences Fully Funded 10,000 Meter Drill Program at the JD Project, Toodoggone Mining District, B.C.
